Form 4: ANI Pharmaceuticals Executive Marken James G. Reports Stock Transaction
SEC Form 4 Filing
SVP of Operations and Product Development at ANI Pharmaceuticals, James G. Marken, reports disposition of shares for tax purposes following vesting of restricted stock.
Summary
- On February 29, 2024, James G. Marken, SVP of Operations and Product Development at ANI Pharmaceuticals, reported a transaction involving common stock.
- A total of 1,058 shares were disposed of at a price of $67.67 per share to cover tax obligations.
- This transaction occurred due to the vesting of 3,256 shares of restricted stock.
- Following the reported transaction, Marken directly owns 148,830 shares of ANI Pharmaceuticals Inc.
Sentiment
Score: 5
Explanation: This is a routine filing related to stock transactions for tax purposes, so the sentiment is neutral.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to monitor potential alignment of interests between management and shareholders.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a standard procedure for covering tax obligations.
Key Dates
| Date | Description |
|---|---|
| 02/29/2024 | Date of stock transaction (disposal of shares). |
| 03/01/2024 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.